QUEBEC

Domain Therapeutics to Participate at Premier Investor and Healthcare Conferences

Retrieved on: 
Monday, April 8, 2024
Research, Clinical Trials, Biotechnology, Health, Pharmaceutical, General Health, Other Science, Science, Oncology, G protein-coupled receptor, Multimedia, Gq alpha subunit, Pharmaceutical industry

Domain Therapeutics (“Domain” or “the Company”), a global clinical-stage biopharmaceutical company developing innovative drug candidates in immuno-oncology targeting G Protein-Coupled Receptors (GPCRs), today announced its President and Chief Executive Officer, Anthony Johnson, M.D., and its Chief Business Officer, Sean A. MacDonald, will participate in the following investor, partnering and healthcare industry conferences in April-May, 2024:

Key Points: 
  • Domain Therapeutics (“Domain” or “the Company”), a global clinical-stage biopharmaceutical company developing innovative drug candidates in immuno-oncology targeting G Protein-Coupled Receptors (GPCRs), today announced its President and Chief Executive Officer, Anthony Johnson, M.D., and its Chief Business Officer, Sean A. MacDonald, will participate in the following investor, partnering and healthcare industry conferences in April-May, 2024:
    This press release features multimedia.
  • View the full release here: https://www.businesswire.com/news/home/20240408769768/en/
    Anthony Johnson & Sean A. MacDonald (Photo: Domain Therapeutics)
    Location: Metro Toronto Convention Centre (North Building), Toronto, Canada

Ventus Therapeutics to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference

Retrieved on: 
Monday, April 8, 2024
Health, Neurology, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Inflammation, Therapy, Conference

Ventus Therapeutics, Inc. , a clinical-stage biopharmaceutical company utilizing its deep protein science expertise and proprietary computational chemistry platform, ReSOLVE™, to develop novel small molecule therapeutics for immunology, inflammation, and neurology disorders, announced today that its President and Chief Executive Officer, Marcelo Bigal, M.D., Ph.D., will present at the 2024 Bloom Burton & Co. Healthcare Investor Conference, being held April 16-17 in Toronto.

Key Points: 
  • Ventus Therapeutics, Inc. , a clinical-stage biopharmaceutical company utilizing its deep protein science expertise and proprietary computational chemistry platform, ReSOLVE™, to develop novel small molecule therapeutics for immunology, inflammation, and neurology disorders, announced today that its President and Chief Executive Officer, Marcelo Bigal, M.D., Ph.D., will present at the 2024 Bloom Burton & Co. Healthcare Investor Conference, being held April 16-17 in Toronto.
  • Dr. Bigal will be presenting on April 16th at 11:30 AM ET.

M1 Composites Technology Becomes Preferred A220 Repair Center

Retrieved on: 
Tuesday, April 9, 2024
QC, Airbus, A220, Satair, Engineering, Airline

LAVAL, QC, April 9, 2024 /PRNewswire/ - M1 Composites Technology Inc, a leading Quebec-based aerostructure engineering, manufacturing, and sustainment/repair company has been selected by Satair, an Airbus Services company, as the preferred North American repair station for Airbus A220  aircraft flight controls and structural parts.

Key Points: 
  • LAVAL, QC, April 9, 2024 /PRNewswire/ - M1 Composites Technology Inc, a leading Quebec-based aerostructure engineering, manufacturing, and sustainment/repair company has been selected by Satair, an Airbus Services company, as the preferred North American repair station for Airbus A220  aircraft flight controls and structural parts.
  • Based in Laval, M1 Composites competed against several large and well-established engineering & repair companies for this contract, which is expected to generate new jobs for the 100-person company.
  • As the North American preferred repair station, M1 Composites will ensure these operators have access to reliable and efficient aerostructure maintenance solutions.
  • Given the integrated aerospace supply chain that exists between both Canada and the U.S., M1 Composites is well-positioned to aid operators in the region with repair solutions on aero structure.

Galaxy Announces Upsize of Bought Deal Financing to Approximately US$125 Million

Retrieved on: 
Tuesday, April 9, 2024
Common stock, Offering, Underwriting, Sale, Regulation, TSX, Galaxy, Person, Security (finance)

NEW YORK, April 9, 2024 /CNW/ - Galaxy Digital Holdings Ltd. (TSX: GLXY) ("Galaxy" or the "Company") is pleased to announce that it has agreed to increase the size of its previously announced bought deal financing with Canaccord Genuity Corp. (the "Underwriter").

Key Points: 
  • NEW YORK, April 9, 2024 /CNW/ - Galaxy Digital Holdings Ltd. (TSX: GLXY) ("Galaxy" or the "Company") is pleased to announce that it has agreed to increase the size of its previously announced bought deal financing with Canaccord Genuity Corp. (the "Underwriter").
  • The Underwriter has agreed to purchase, on a bought deal basis, an additional 2,350,000 ordinary shares of the Company (the "Ordinary Shares") at a price of C$14.00 per Ordinary Share (the "Issue Price").
  • As a result of the upsize, the aggregate number of Ordinary Shares purchase by the Underwriter shall be 12,100,000 Ordinary Shares, for aggregate gross proceeds to the Company of C$169,400,000 (or approximately US$125 million equivalent) (the "Offering").
  • The Prospectus Supplement will be filed on SEDAR+ at www.sedarplus.ca on or before April 11, 2024.

Syntax and Cogniac Forge Partnership to Empower Industries with Enterprise-Grade Computer Vision AI

Retrieved on: 
Tuesday, April 9, 2024
Automation, PLC, RPA, Partnership, ERP, Electronics, Artificial intelligence, SAP, MES, Schuler, Programmable logic controller, Computer vision, Safety, Computer, Robotic process automation, Smart, Retail

MONTREAL, April 9, 2024 /PRNewswire/ -- Syntax Systems, a leading global technology solutions and services provider for cloud application implementation and management, today announced its partnership with Cogniac Corporation, a global leader in enterprise-grade computer vision, to accelerate the development of industrial AI applications. In joining forces, the two companies will enhance the automation of manufacturing processes through the integration of advanced computer vision capabilities.

Key Points: 
  • In joining forces, the two companies will enhance the automation of manufacturing processes through the integration of advanced computer vision capabilities.
  • This partnership will enable Syntax and Cogniac to bring innovative enterprise planning and vision systems to its core customer base at scale across automotive, electronics, construction, packaged foods and more.
  • "This partnership with Syntax is yet another significant milestone for Cogniac as we continue to make rapid strides in implementing computer vision solutions deployed in Smart Factory environments," said Quinn Curtis, CEO of Cogniac.
  • To learn more about this collaboration and how to get started with computer AI implementation, visit Syntax's website .

GLOBOCAM OPENS A NEW DEALERSHIP IN CORNWALL, ONTARIO

Retrieved on: 
Tuesday, April 9, 2024
Travel

CORNWALL, ON, April 9, 2024 /PRNewswire/ - GLOBOCAM, the largest network of heavy-duty truck dealerships in Quebec, is proud to announce the opening of a brand-new sales, parts, and service dealership in the Cornwall region.

Key Points: 
  • CORNWALL, ON, April 9, 2024 /PRNewswire/ - GLOBOCAM, the largest network of heavy-duty truck dealerships in Quebec, is proud to announce the opening of a brand-new sales, parts, and service dealership in the Cornwall region.
  • This opening marks an important step in GLOBOCAM's growth plan, as it establishes its operations for the first-time outside Quebec in the Ontario market.
  • GLOBOCAM now becomes the exclusive distributor of Freightliner and Western Star trucks in the Cornwall region.
  • With this 10th location in Canada, GLOBOCAM is pursuing its ambitious goal of delivering 2,500 trucks a year by 2025.

Bell Canada partners with Google Cloud to power their AI-driven contact centre revolution for Canadian businesses

Retrieved on: 
Tuesday, April 9, 2024
Cloud, Automation, Industry analyst, Google Cloud, Data engineering, Bell Canada, Intelligence, Partnership, SVP, Knowledge, AI, Partner, CCAI, Sales

Providing rich conversational experiences and analytics, Google CCAI from Bell offers scalability and flexibility that can be added to existing contact centre environments and to cloud contact centres of any size.

Key Points: 
  • Providing rich conversational experiences and analytics, Google CCAI from Bell offers scalability and flexibility that can be added to existing contact centre environments and to cloud contact centres of any size.
  • As a Premier Level Partner for Google Cloud in the Sell Engagement Model and 2024 Google Cloud sales Partner of the Year - Canada recipient, Bell offers enhanced expertise within Google Cloud.
  • Bell will now add Google CCAI solutions to its Contact Centre Practice, which has a proven track record of successful premise and cloud contact centre implementations with a commitment to customer satisfaction.
  • Bell itself is undergoing a company-wide digital transformation, and in addition to Google CCAI services, is in the process of deploying other solutions within its contact centres, including Google Cloud Contact Centre AI Platform.

enGene Announces Hiring of Dr. Raj Pruthi as Senior Vice President, Urologic Oncology and Clinical Development

Retrieved on: 
Tuesday, April 9, 2024
NMIBC, BCG, American Urological Association, Master, Professor, Advisory Council, Patient, SVP, Thesis, University, Drug, Society, American College, LEGEND, Bladder cancer, Hofstra University, FACS, Stanford University, AUA, Prostate, Medicine, Pharmaceutical industry

In this role, Dr. Pruthi's responsibilities will include supporting the clinical development of EG-70 across the urologic space, including through engagement with the urological community.

Key Points: 
  • In this role, Dr. Pruthi's responsibilities will include supporting the clinical development of EG-70 across the urologic space, including through engagement with the urological community.
  • He joins enGene from Johnson & Johnson Innovative Medicine, where he was most recently the Global Medical Affairs Leader, Bladder Cancer and Senior Medical Director, Oncology (Global – Prostate and Bladder Cancer).
  • "We are thrilled to welcome Dr. Raj Pruthi to the enGene team.
  • In addition to his position at enGene, Dr. Pruthi maintains multiple prominent leadership roles within the urological community.

Averna Announces the Acquisition of Automated Test Solutions Provider ELCOM, a. s.

Retrieved on: 
Tuesday, April 9, 2024
CEIP, Acquisition, Electronics, Engineering, Growth, Management

MONTREAL, April 9, 2024 /PRNewswire/ - Averna , a leading global test & quality solutions provider, announced the acquisition of ELCOM, a. s. and subsidiaries.

Key Points: 
  • MONTREAL, April 9, 2024 /PRNewswire/ - Averna , a leading global test & quality solutions provider, announced the acquisition of ELCOM, a. s. and subsidiaries.
  • ELCOM is a renowned player in test & measurement, power engineering and industrial automation.
  • In a statement regarding the acquisition, President and CEO of Averna, François Rainville said, "We are excited to welcome ELCOM into the Averna family.
  • Now, with more than 575 employees worldwide, Averna is consolidating its position as a leading global test engineering solutions integrator for automotive/transport, medical devices/pharma, consumer electronics and industrial product manufacturers.

Averna Announces the Acquisition of Automated Test Solutions Provider ELCOM, a. s.

Retrieved on: 
Tuesday, April 9, 2024
CEIP, Acquisition, Electronics, Engineering, Growth, Management

MONTREAL, April 9, 2024 /PRNewswire/ -- Averna, a leading global test & quality solutions provider, announced the acquisition of ELCOM, a. s. and subsidiaries. ELCOM is a renowned player in test & measurement, power engineering and industrial automation.

Key Points: 
  • MONTREAL, April 9, 2024 /PRNewswire/ -- Averna , a leading global test & quality solutions provider, announced the acquisition of ELCOM, a. s. and subsidiaries.
  • ELCOM is a renowned player in test & measurement, power engineering and industrial automation.
  • In a statement regarding the acquisition, President and CEO of Averna, François Rainville said, "We are excited to welcome ELCOM into the Averna family.
  • Now, with more than 575 employees worldwide, Averna is consolidating its position as a leading global test engineering solutions integrator for automotive/transport, medical devices/pharma, consumer electronics and industrial product manufacturers.